Pharmaceutical inhibition of MMP-13 resulted in reduced arthritis in the collagen-induced arthritis and severe combined immunodeficiency mouse coimplantation model, but not in the antibody-induced arthritis model [16]. The gene discussed is MMP13; the disease is arthritic joint disease.